BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Antonioli L, Lucarini E, Lambertucci C, Fornai M, Pellegrini C, Benvenuti L, Di Cesare Mannelli L, Spinaci A, Marucci G, Blandizzi C, Ghelardini C, Volpini R, Dal Ben D. The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis. Cells 2020;9:E1509. [PMID: 32575844 DOI: 10.3390/cells9061509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bova V, Filippone A, Casili G, Lanza M, Campolo M, Capra AP, Repici A, Crupi L, Motta G, Colarossi C, Chisari G, Cuzzocrea S, Esposito E, Paterniti I. Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness. Cancers (Basel) 2022;14:4032. [PMID: 36011024 DOI: 10.3390/cancers14164032] [Reference Citation Analysis]
2 Suresh RR, Gao ZG, Salmaso V, Chen E, Campbell RG, Poe RB, Liston TE, Jacobson KA. Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species. ACS Med Chem Lett 2022;13:623-31. [PMID: 35450351 DOI: 10.1021/acsmedchemlett.1c00685] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang J, Bhattarai A, Do HN, Akhter S, Miao Y. Molecular Simulations and Drug Discovery of Adenosine Receptors. Molecules 2022;27:2054. [PMID: 35408454 DOI: 10.3390/molecules27072054] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tosh DK, Salmaso V, Campbell RG, Rao H, Bitant A, Pottie E, Stove CP, Liu N, Gavrilova O, Gao ZG, Auchampach JA, Jacobson KA. A3 adenosine receptor agonists containing dopamine moieties for enhanced interspecies affinity. Eur J Med Chem 2022;228:113983. [PMID: 34844790 DOI: 10.1016/j.ejmech.2021.113983] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Saini A, Patel R, Gaba S, Singh G, Gupta GD, Monga V. Adenosine receptor antagonists: Recent advances and therapeutic perspective. Eur J Med Chem 2021;227:113907. [PMID: 34695776 DOI: 10.1016/j.ejmech.2021.113907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
6 Ceruti S. From astrocytes to satellite glial cells and back: A 25 year-long journey through the purinergic modulation of glial functions in pain and more. Biochem Pharmacol 2021;187:114397. [PMID: 33382970 DOI: 10.1016/j.bcp.2020.114397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Vincenzi F, Pasquini S, Borea PA, Varani K. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain. Int J Mol Sci 2020;21:E8710. [PMID: 33218074 DOI: 10.3390/ijms21228710] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]